New Drug: Tivozanib for advanced clear cell renal cell carcinoma
|New Drug: Tivozanib for advanced clear cell renal cell carcinoma|
Lancet Oncol 2020; 21: 95–104
Rini BI, et al. Tivozanib versus sorafenib in patients with advanced renal cell carcinoma (TIVO-3): a phase 3, multicentre, randomised, controlled, open-label studyhttps://doi.org/10.1016/S1470-2045(19)30735-1
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.